Co-funding Institute(s):
National Institute on Aging (NIA)
Drug Discovery for Neurodegeneration
February 2, 2009 - February 3, 2009
Washington, DC, United States
Contact for additional information: Dr. Suzana Petanceska, NIA 301-594-7754
DescriptionThe objectives of this Alzheimer's Drug Discovery Foundation (ADDF) conference are to (1) train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease; (2) provide a platform for scientists to exchange ideas, knowledge, and resources about drug discovery for neurodegenerative disease; (3) stimulate preclinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of neurodegenerative disease; (4) build public-private partnerships that will accelerate drug discovery for neurodegenerative disease; (5) publish the conference proceedings in a scientific journal available on PubMed; and (6) provide continuing medical education (CME) credits.
Additional Information: Conference Web Site
|